FDA Approved: POSACONAZOLE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' posaconazole under an Original Application (ANDA), marking a generic approval for this antifungal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Fungal Infections
• Mucormycosis
• Oropharyngeal Candidiasis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)